-transparent.png){kind=logo}
The varicella-zoster virus (VZV) thymidine kinase (TK) EC 2.7.2.21) catalyzes the phosphorylation of many anti-VZV nucleosides. Purified, bacterially expressed VZV TK was characterized with regard to N-terminal amino acid sequence, pI value, pH optimum, metal ion requirement, phosphate donor and acceptor specificity, and inhibition by dTTP. Initial velocities of thymidine phosphorylation with variable MgATP concentrations fit a two-site model with apparent Km values for MgATP of 0.10 and 900 microM. dTTP was a noncompetitive inhibitor of thymidine phosphorylation but was competitive with MgATP. Phosphate donor and acceptor specificities of the bacterially expressed enzyme were indistinguishable from those of VZV TK purified from infected cells. Detailed studies of the nucleoside specificity with the bacterially expressed enzyme showed that, for a given sugar moiety, thymine nucleosides were the most efficient substrates followed by nucleosides of cytosine, uracil, adenine, and with some exceptions, guanine. For a given pyrimidine or purine (except guanine), 2'-deoxyribonucleosides were the most efficient substrates, followed by arabinosides, ribonucleosides, 2',3'-dideoxyribonucleosides, and the acyclic moiety of acyclovir.
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
March 1986,
Biken journal,
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
July 2003,
The Journal of biological chemistry,
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
June 1986,
Antimicrobial agents and chemotherapy,
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
June 1993,
The Journal of general virology,
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
April 1982,
Infection and immunity,
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
April 2003,
European journal of medicinal chemistry,
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
September 1994,
Antimicrobial agents and chemotherapy,
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
April 2000,
Protein expression and purification,
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
April 1992,
Journal of virology,
G B Roberts, and
J A Fyfe, and
S A McKee, and
S G Rahim, and
S M Daluge, and
M R Almond, and
J L Rideout, and
G W Koszalka, and
T A Krenitsky
January 1986,
Antimicrobial agents and chemotherapy,
